Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2542PDF: 1966HTML: 1098 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3134PDF: 1496HTML: 3750Untitled: 290Untitled: 284Untitled: 236 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
995PDF: 195HTML: 239 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
659PDF: 330HTML: 170 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1479PDF: 1179HTML: 285 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1279PDF: 1273Suppl. Files: 615HTML: 117 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1796HTML: 737PDF: 954 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
4059PDF: 1814HTML: 12000Figures Haase: 332 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3613PDF: 2147HTML: 7599 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2177PDF: 884HTML: 740Table1: patient's characteristics: 277Table 2: profile of each patient: 263 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2682HTML: 376PDF: 1001 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
4020PDF: 1367HTML: 5109Incidence age-standardized rates for HL across the Mediterranean basin: 283 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3481PDF: 1828HTML: 1199 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2795PDF: 912HTML: 5412 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9670PDF: 6386HTML: 88353Fig.1b: 322Fig.1c: 335Fig.2a: 327Fig.2b: 290Fig.4: 361Fig.2c: 309Fig.3: 306Tab.1: 368Tab.2: 338Tab.3: 333Tab.4: 384Fig1a: 320 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1827PDF: 1184HTML: 532 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3905PDF: 2695HTML: 1733 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3929PDF: 1016HTML: 6901 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
3428PDF: 1160HTML: 360Suppl. Files: 550 -
SOLITARY PLASMACYTOMA
4465PDF: 2330HTML: 1458fIGURES 1,2: 303 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2402PDF: 1756HTML: 754 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3356PDF: 985HTML: 7330Kost Fig1: 256Kost Fig 2: 236Kost Fig3: 254Kost Fig 4: 271Kost Fig5: 255Kost fig 6: 255 -
-
TYROSINE KINASE INHIBITORS AND PREGNANCY
3949PDF: 1840HTML: 2787 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2698PDF: 897HTML: 1770 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4274PDF: 1690HTML: 9338Untitled: 370Untitled: 242Untitled: 231Untitled: 251Untitled: 241Untitled: 415 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
3013PDF: 1306HTML: 3341 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4181PDF: 1161HTML: 3931Untitled: 216Cneo. Fig.1: 150Untitled: 145Untitled: 186Untitled: 188 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3157PDF: 1133HTML: 5689







